abstract |
The invention described herein relates to diagnosis, imaging and / or treatment of pathogenic cell populations. More specifically, the invention described herein relates to the diagnosis, imaging and / or treatment of diseases caused by PSMA-expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA-expressing cells. |